{"title": "Clinical Trial Finder | Pancreatic Cancer Action Network", "author": null, "url": null, "hostname": null, "description": "The Pancreatic Cancer Action Network's Clinical Trial Finder connects pancreatic cancer patients and researchers with clinical research trials.", "sitename": null, "date": "2007-01-01", "cleaned_text": "Phase Ib/II Study of Molecularly Informed Integrated Immunotherapy Combining Innate High-affinity Natural Killer (haNK) Cell Therapy With Adenoviral and Yeast-based Vaccines to Induce T-cell Responses in Patients With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy (NANT Pancreatic Cancer Vaccine) Summary The purpose of this phase Ib/II study is to evaluate the safety and efficacy of metronomic combination therapy in patients with pancreatic cancer who have progressed on or after previous Standard of Care chemotherapy. General Information NCT#: NCT03387098 Study ID: QUILT-3.070 Trial Phase: Cancer Vaccine, ALT-803/N-803, ETBX-011, GI-4000 vaccine "}